Fig 2 - uploaded by Patrick Frosk
Content may be subject to copyright.
Photomicrographs of the striatum showing ( A ) normal neuron density (neurons indicated by arrows) in an age-matched control and ( B ) severe loss of neurons in the same area of GA-1 Case 5. (H&E stained sections, 40 3 objective magnification, bar = 20 m m). 

Photomicrographs of the striatum showing ( A ) normal neuron density (neurons indicated by arrows) in an age-matched control and ( B ) severe loss of neurons in the same area of GA-1 Case 5. (H&E stained sections, 40 3 objective magnification, bar = 20 m m). 

Source publication
Article
Full-text available
Glutaric acidemia type 1 (GA-1) is an autosomal recessive disorder characterized by a deficiency of glutaryl-CoA dehydrogenase (GCDH) activity. GA-1 is often associated with an acute encephalopathy between 6 and 18 months of age that causes striatal damage resulting in a severe dystonic movement disorder. Ten autopsy cases have been previously desc...

Context in source publication

Context 1
... but failed to thrive and had multiple respiratory infections. At 15 months, he was unable to sit but had some head control and visual interaction. During a febrile illness at 18 months, he stopped breathing. Autopsy revealed laryngitis and dehydration. His head circumference had been on the 52 percentile at birth, 89 percentile at 3 months, 63 percentile at 8 months and was on the 50 percentile at the time of death. The brain exhibited mild widening of temporal and frontal sulci, and pronounced widening of the Sylvian fissures. No histological abnormalities were apparent in the cerebral cortex of the temporal lobe tips or frontal lobes. The caudate nuclei were small, yellowish and firm. There was symmetric lateral ventricle enlargement ( Fig. 1). The head of the caudate and the putamen exhibited severe neuronal loss with pronounced reactive astrocytes. Only rare reactive microglia were identified. The tail of the caudate adjacent to the hippocampus appeared normal. The cerebral white matter exhibited no vacuoles, no damaged axons were identified using amyloid precursor protein immunohistochemistry, and no myelin debris could be demonstrated with the Marchi method. Rare vacuoles were present in the central tegmental tract at the level of the midbrain. This female born by forceps delivery at 37 weeks gestation, in 1983, had generalized hypotonia in infancy. She is Case 1 in pedigree A described in the clinical report of this cohort (Haworth et al ., 1991). At 6 months of age, she developed seizures and choreoathetoid movements. Thereafter she developed severe spastic quadriparesis. She was unable to walk and developed severe scoliosis. A CT scan at 5 years showed enlarged frontal horns and slightly wide Sylvian fissures. She died of acute pneumonia at age 7 years. Her head circumference had been on the 25 percentile at birth, 52 percentile at 6 months, 3 percentile at 19 months and 25 percentile at the time of death. Her brain exhibited mild gyral flattening, slightly enlarged ventricles and severe striatal atrophy. The caudate and putamen had a near complete loss of medium size neurons (Fig. 2) and some GFAP immunoreactive astrocytes; the nucleus accumbens was spared. Scattered hypertrophic astrocytes and very rare HLA-DR immunoreactive microglia were present in the internal capsule— although there were no vacuoles. There were small foci of spongiform change in the frontal and insular cortex. This male born at 40 weeks gestation, in 1953, was apparently slow to breathe. He had three siblings that died in infancy from pneumonia. He is Case 14 in pedigree E described in the clinical report of this cohort (Haworth et al ., 1991). At 12 months of age, he developed a high fever and was admitted to hospital with dystonia. At 6 years, he was documented to have severe flexor spasticity of the arms and legs, choreoathetoid movements and oral dyskinesia. Seizures were reported only early in life. He resided in a nursing care facility for his entire life. At no time was brain imaging conducted and head circumference information was not available. He required many hospitalizations for aspiration pneumonia. On one such admission at age 40 years, the treatment was complicated by pseudomembranous colitis from which he died. His brain had a normal external appearance. The frontal horns of the lateral ventricles were moder- ately enlarged. There was marked atrophy of the caudate and putamen with neuronal loss and abundant corpora amylacea. There was no significant immunoreactivity for GFAP or HLA-DR. The anterior nucleus accumbens was spared. The white matter of the cerebrum and brainstem was well myelinated and no vacuoles were identified. Subtle chronic astrogliosis, demonstrable with modified phosphotungstic acid haematoxylin (PTAH) stain, was evident in the inferior olivary nuclei but there was no obvious neuron loss. Very rare empty basket cells were present in the cerebellum, suggestive of mild Purkinje cell loss. Frontal cortex tissue was examined in all cases, none provided evidence of obvious cell loss or reactive changes. Quantitative comparison of the striatum in GA 1 cases and controls showed statistically significant ( P < 0.05) loss ...

Similar publications

Article
Full-text available
Key-words Disease name and synomyms Diagnosis criteria/definition Differential diagnosis Incidence Clinical description Treatment Etiology Abstract Glutaryl-Coenzyme A (CoA) dehydrogenase deficiency (GDD) is an autosomal recessive neurometabolic disorder with an estimated incidence of 1:50,000 newborn Caucasians. It is caused by mutations in the gl...
Article
Full-text available
Glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency) is an inborn error of metabolism that usually manifests in infancy by an acute encephalopathic crisis and often results in permanent motor handicap. Biochemical hallmarks of this disease are elevated levels of glutarate and 3-hydroxyglutarate in blood and urine. The neuropathology of...
Article
Full-text available
Glutaric acidaemia type I (GA I) is caused by the deficiency of glutaryl-CoA dehydrogenase, resulting in accumulation of glutaric acid (GA) and 3- hydroxyglutaric acid (3-OH-GA) in blood and cerebrospinal fluid (CSF). Neuropathological changes with onset in childhood consist of severe neuronal loss in the caudate and putamen. An animal model is nec...
Article
Full-text available
Acute neurological crises involving striatal degeneration induced by a deficiency of glutaryl-CoA dehydrogenase (GCDH) and the accumulation of glutaric (GA) and 3-hydroxyglutaric acid (3-OHGA) are considered to be the most striking features of glutaric aciduria type I (GA1). In the present study, we investigated the mechanisms of apoptosis and ener...
Article
Full-text available
La aciduria glutárica tipo I se produce por deficiencia de la enzima glutaril-CoA deshidrogenasa involucrada en el catabolismo de la L-lisina, L-hidroxilisina y L-triptófano lo que ocasiona acumulación de los ácidos glutárico y 3 hidroxiglutárico responsables del compromiso neurológico severo característico de esta enfermedad. La sospecha y diagnós...

Citations

... For GA-1, several genetic isolates sharing the same variant have been reported with higher prevalence in some populations compared with the worldwide prevalence. For instance, in the aboriginal population of Island Lake, Manitoba and northwestern Ontario, GA-1 has a higher prevalence and c.91+5G>T p.(?) was the only pathogenic allele identified among affected individuals [55][56][57][58][59]. The geographic distribution of GCDH variants is also relevant for further studies, e.g., on the correlation of genotype and clinical phenotype. ...
Article
Full-text available
Glutaric aciduria type 1 (GA-1) is a rare but treatable autosomal-recessive neurometabolic disorder of lysin metabolism caused by biallelic pathogenic variants in glutaryl-CoA dehydrogenase gene (GCDH) that lead to deficiency of GCDH protein. Without treatment, this enzyme defect causes a neurological phenotype characterized by movement disorder and cognitive impairment. Based on a comprehensive literature search, we established a large dataset of GCDH variants using the Leiden Open Variation Database (LOVD) to summarize the known genotypes and the clinical and biochemical phenotypes associated with GA-1. With these data, we developed a GCDH-specific variation classification framework based on American College of Medical Genetics and Genomics and the Association for Molecular Pathology guidelines. We used this framework to reclassify published variants and to describe their geographic distribution, both of which have practical implications for the molecular genetic diagnosis of GA-1. The freely available GCDH-specific LOVD dataset provides a basis for diagnostic laboratories and researchers to further optimize their knowledge and molecular diagnosis of this rare disease.
... Bilateral striatal necrosis was previously pathologically and clinically found in patients with GA-1, resulting in a severe dystonic movement disorder. [4][5][6] The clinical manifestations of patients with GA-1 include an acute encephalopathic crisis precipitated by intercurrent febrile illness, macrocephalus, hypotonia, and choreoathetosis and seizures, and patients usually end with permanent motor and mental disability. ...
Article
Background and purpose: Routine MR imaging has limited use in evaluating the severity of glutaric aciduria type 1. To better understand the mechanisms of brain injury in glutaric aciduria type 1, we explored the value of diffusional kurtosis imaging in detecting microstructural injury of the gray and white matter. Materials and methods: This study included 17 patients with glutaric aciduria type 1 and 17 healthy controls who underwent conventional MR imaging and diffusional kurtosis imaging. The diffusional kurtosis imaging metrics of the gray and white matter were measured. Then, the MR imaging scores and diffusional kurtosis imaging metrics of all ROIs were further correlated with the morbidity scores and Barry-Albright dystonia scores. Results: The MR imaging scores showed no significant relation to the morbidity and Barry-Albright dystonia scores. Compared with healthy controls, patients with glutaric aciduria type 1 showed higher kurtosis values in the basal ganglia, corona radiata, centrum semiovale, and temporal lobe (P < .05). The DTI metrics of the basal ganglia were higher than those of healthy controls (P < .05). The fractional anisotropy value of the temporal lobe and the mean diffusivity values of basal ganglia in glutaric aciduria type 1 were lower than those in the control group (P < .05). The diffusional kurtosis imaging metrics of the temporal lobe and basal ganglia were significantly correlated with the Barry-Albright dystonia scores. The mean kurtosis values of the anterior and posterior putamen and Barry-Albright dystonia scores were most relevant (r = 0.721, 0.730, respectively). The mean kurtosis values of the basal ganglia had the best diagnostic efficiency with area under the curve values of 0.837 for the temporal lobe, and the mean diffusivity values of the basal ganglia in glutaric aciduria type 1 were lower than those in the control group (P < .05). The diffusional kurtosis imaging metrics of the temporal lobe and basal ganglia were significantly correlated with the Barry-Albright dystonia scores. The mean kurtosis values of the anterior and posterior putamen and Barry-Albright dystonia scores were most relevant (r = 0.721, 0.730, respectively). The mean kurtosis values of the basal ganglia had the best diagnostic efficiency with area under the curve values of 0.837. Conclusions: Diffusional kurtosis imaging provides more comprehensive quantitative information regarding the gray and white matter micropathologic damage in glutaric aciduria type 1 than routine MR imaging scores.
... Glutamate, which is not only produced in the metabolism of saccharopine but can also be derived from extracellular glutamine, demonstrated only modest increases in abundance (log 2 fold change = 0.27, q = 0.01). Notably, the accumulation of 3-hydroxyglutarate and glutarate in the urine phenocopies the presentation of glutaric aciduria type I, an autosomal recessive disorder caused by a deficiency in glutaryl-CoA dehydrogenase (GCDH), which catalyzes the conversion of glutaryl-CoA to crotonyl-CoA (19)(20)(21). GCDH is neither underexpressed nor mutated in HCC tumors. GCDH oxidizes glutaryl-CoA and transfers them to the electron transfer flavoprotein, an electron acceptor for a wide spectrum of dehydrogenases that ultimately donates electrons to the ubiquinone pool in the mitochondrial electron transport chain (ETC). ...
Article
Full-text available
Hürthle cell carcinomas (HCCs) display two exceptional genotypes: near-homoplasmic mutation of mitochondrial DNA (mtDNA) and genome-wide loss of heterozygosity (gLOH). To understand the phenotypic consequences of these genetic alterations, we analyzed genomic, metabolomic, and immunophenotypic data of HCC and other thyroid cancers. Both mtDNA mutations and profound depletion of citrate pools are common in HCC and other thyroid malignancies, suggesting that thyroid cancers are broadly equipped to survive tricarboxylic acid cycle impairment, whereas metabolites in the reduced form of NADH-dependent lysine degradation pathway were elevated exclusively in HCC. The presence of gLOH was not associated with metabolic phenotypes but rather with reduced immune infiltration, indicating that gLOH confers a selective advantage partially through immunosuppression. Unsupervised multimodal clustering revealed four clusters of HCC with distinct clinical, metabolomic, and microenvironmental phenotypes but overlapping genotypes. These findings chart the metabolic and microenvironmental landscape of HCC and shed light on the interaction between genotype, metabolism, and the microenvironment in cancer.
... Accumulating GA and 3-hydroxyglutaric acid affect cellular functions on multiple levels impairing Krebs cycle enzymes 38 , interfering with anaplerotic transport processes between astrocytes and neurons 39 as well as glutamatergic and GABAergic neurotransmission 40 , thus inducing brain energy impairment 38 , and generating increased amounts of reactive oxygen species 41,42 . Post-mortem studies showed massive accumulation of GA and 3-hydroxyglutaric acid 43 , which was explained by intracerebral de novo synthesis and entrapment of toxic metabolites due to limited permeability of the blood-brain barrier for dicarboxylic acids 44 , corresponding to the similarly high a priori risk of striatal damage in both HE and LE patients 2,3 . As an additional possible mechanism explaining differences between individuals with HE and LE subtype, selective glutarylation of more than 30 mitochondrial proteins exclusively localized in astroglial cells of Gcdh-deficient mice was recently demonstrated resulting in reduced catalytic activity, stability and protein-protein interaction of glutamate dehydrogenase and brain-specific carbonic anhydrase 5b. ...
... Accumulating GA and 3-hydroxyglutaric acid affect cellular functions on multiple levels impairing Krebs cycle enzymes 38 , interfering with anaplerotic transport processes between astrocytes and neurons 39 as well as glutamatergic and GABAergic neurotransmission 40 , thus inducing brain energy impairment 38 , and generating increased amounts of reactive oxygen species 41,42 . Post-mortem studies showed massive accumulation of GA and 3-hydroxyglutaric acid 43 , which was explained by intracerebral de novo synthesis and entrapment of toxic metabolites due to limited permeability of the blood-brain barrier for dicarboxylic acids 44 , corresponding to the similarly high a priori risk of striatal damage in both HE and LE patients 2,3 . As an additional possible mechanism explaining differences between individuals with HE and LE subtype, selective glutarylation of more than 30 mitochondrial proteins exclusively localized in astroglial cells of Gcdh-deficient mice was recently demonstrated resulting in reduced catalytic activity, stability and protein-protein interaction of glutamate dehydrogenase and brain-specific carbonic anhydrase 5b. ...
Article
Full-text available
The aim of the study was a systematic evaluation of cognitive development in individuals with glutaric aciduria type 1 (GA1), a rare neurometabolic disorder, identified by newborn screening in Germany. This national, prospective, observational, multi-centre study includes 107 individuals with confirmed GA1 identified by newborn screening between 1999 and 2020 in Germany. Clinical status, development, and IQ were assessed using standardized tests. Impact of interventional and non-interventional parameters on cognitive outcome was evaluated. The majority of tested individuals (n = 72) showed stable IQ values with age (n = 56 with IQ test; median test age 11 years) but a significantly lower performance (median [IQR] IQ 87 [78–98]) than in general population, particularly in individuals with a biochemical high excreter phenotype (84 [75–96]) compared to the low excreter group (98 [92–105]; p = 0.0164). For all patients, IQ results were homogenous on subscale levels. Sex, clinical motor phenotype and quality of metabolic treatment had no impact on cognitive functions. Long-term neurologic outcome in GA1 involves both motor and cognitive functions. The biochemical high excreter phenotype is the major risk factor for cognitive impairment while cognitive functions do not appear to be impacted by current therapy and striatal damage. These findings implicate the necessity of new treatment concepts.
... Excitotoxic neuronal degeneration mediated by glutamate receptors is wellknown in neurodegenerative disorders (F. Cicchetti et al., 2009;Coyle & Schwarcz, 1976;Flott-Rahmel et al., 1997;Funk et al., 2005;Rikani et al., 2014). NMDA activation by glutamate can lead to prolonged elevated intracellular calcium by calcium channel associated with NMDA . ...
... This patient was a high excretor who experienced their first crisis before 12 months of age and who went on to develop mental retardation. It has been postulated that p.Arg402Trp and p.Ala293Thr were most frequently identified in high excretors, while p.Val400Met and p.Arg227Pro are only found in low excretors (Busquets et al., 2000;Mühlhausen et al., 2003;Funk et al., 2005;Gallagher et al., 2005). Although p.Arg402Trp accounts for 40% of alleles in patients of German origin (Radha Rama Devi et al., 2016), it was less common in our study. ...
Article
Full-text available
Purpose To characterize the phenotypic and genotypic variations associated with Glutaric aciduria type 1 (GA1) in Chinese patients. Methods We analyzed the clinical, neuroradiological, biochemical, and genetic information from 101 GA1 patients in mainland China. Results 20 patients were diagnosed by newborn screening and the remaining 81 cases were identified following clinical intervention. Macrocephaly was the most common presentation, followed by movement disorders and seizures. A total of 59 patients were evaluated by brain MRI and 58 patients presented with abnormalities, with widening of the sylvian fissures being the most common symptom. The concentration of glutarylcarnitine in the blood, glutarylcarnitine/capryloylcarnitine ratio, and urine levels of glutaric acid were increased in GA1 patients and were shown to decrease following intervention. A total of 88 patient samples were available for genotyping and 74 variants within the GCDH gene, including 23 novel variants, were identified. The most common variant was c.1244-2A > C (18.4%) and there were no significant differences in the biochemical or clinical phenotypes described for patients with the four most common variants: c.1244-2A > C, c.1064G > A, c.533G > A, and c.1147C > T. Patients identified by newborn screening had better outcomes than clinical patients. Conclusion Our findings expand the spectrum of phenotypes and genotypes for GA1 in Chinese populations and suggest that an expanded newborn screening program using tandem mass spectrometry may facilitate the early diagnosis and treatment of this disease, improving clinical outcomes for patients in China.
... Excitotoxic neuronal degeneration mediated by glutamate receptors is wellknown in neurodegenerative disorders (F. Cicchetti et al., 2009;Coyle & Schwarcz, 1976;Flott-Rahmel et al., 1997;Funk et al., 2005;Rikani et al., 2014). NMDA activation by glutamate can lead to prolonged elevated intracellular calcium by calcium channel associated with NMDA . ...
... Excitotoxic neuronal degeneration mediated by glutamate receptors is wellknown in neurodegenerative disorders (F. Cicchetti et al., 2009;Coyle & Schwarcz, 1976;Flott-Rahmel et al., 1997;Funk et al., 2005;Rikani et al., 2014). NMDA activation by glutamate can lead to prolonged elevated intracellular calcium by calcium channel associated with NMDA . ...
... 42,43 In spite of different peripheral concentrations of neurotoxins in urine or blood, post-mortem studies showed a massive intracerebral accumulation of GA and 3OHGA in both, HE and LE patients. 44 This was explained by intracerebral de novo synthesis and entrapment of neurotoxic metabolites due to a limited permeability of the blood-brain barrier for dicarboxylic acids. 5 Consistent with this, HE and LE patients are thought to share the same clinical course, that is, the same risk of developing acute EC and dystonic MD, 1,4 which also was confirmed in our study cohort before. ...
Article
Full-text available
Glutaric aciduria type 1 (GA1) is a rare neurometabolic disorder, caused by inherited deficiency of glutaryl‐CoA dehydrogenase, mostly affecting the brain. Early identification by newborn screening (NBS) significantly improves neurologic outcome. It has remained unclear whether recommended therapy, particular low lysine diet, is safe or negatively affects anthropometric long‐term outcome. This national prospective, observational, multi‐centre study included 79 patients identified by NBS and investigated effects of interventional and non‐interventional parameters on body weight, body length, body mass index (BMI) and head circumference as well as neurological parameters. Adherence to recommended maintenance and emergency treatment (ET) had a positive impact on neurologic outcome and allowed normal anthropometric development until adulthood. In contrast, non‐adherence to ET, resulting in increased risk of dystonia, had a negative impact on body weight (mean SDS −1.07; P = .023) and body length (mean SDS −1.34; P = −.016). Consistently, longitudinal analysis showed a negative influence of severe dystonia on weight and length development over time (P < .001). Macrocephaly was more often found in female (mean SDS 0.56) than in male patients (mean SDS −0.20; P = .049), and also in individuals with high excreter phenotype (mean SDS 0.44) compared to low excreter patients (mean SDS −0.68; P = .016). In GA1, recommended long‐term treatment is effective and allows for normal anthropometric long‐term development up to adolescence, with gender‐ and excreter type‐specific variations. Delayed ET and severe movement disorder result in poor anthropometric outcome.